Amphastar Pharmaceuticals, Inc. (AMPH) stock
AMPHNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 12/3030% below fair value
$29.37+0.50 (+1.73%)
Close on Nov 13, 2026Market cap $1.25BP/E 13.3Yield –
Amphastar Pharmaceuticals operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Amphastar Pharmaceuticals's operating cash flow for the twelve months ending Sep 30, 2026 was $175.33M, up 15.1% year over year. For fiscal 2025 it was $156.12M, down 26.8% from the year before. Over ten years it grew 30.8% a year on average. The highest annual figure on record is $213.39M in fiscal 2024.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $156.12M | -26.8% |
| FY2024 | Dec 31, 2024 | $213.39M | +16.3% |
| FY2023 | Dec 31, 2023 | $183.50M | +105.8% |
| FY2022 | Dec 31, 2022 | $89.18M | -9.0% |
| FY2021 | Dec 31, 2021 | $97.99M | +71.1% |
| FY2020 | Dec 31, 2020 | $57.27M | +37.1% |
| FY2019 | Dec 31, 2019 | $41.76M | +9.4% |
| FY2018 | Dec 31, 2018 | $38.19M | -2.6% |
| FY2017 | Dec 31, 2017 | $39.21M | +1.7% |
| FY2016 | Dec 31, 2016 | $38.56M | +261.0% |
| FY2015 | Dec 31, 2015 | $10.68M | -49.3% |
| FY2014 | Dec 31, 2014 | $21.05M | -32.2% |
| FY2013 | Dec 31, 2013 | $31.04M | – |
| FY2012 | Dec 31, 2012 | -$1.65M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $43.30M | -17.7% |
| Q2 FY2026 | Jun 30, 2026 | $51.32M | +44.2% |
| Q1 FY2026 | Mar 31, 2026 | $47.84M | +36.4% |
| Q4 FY2025 | Dec 31, 2025 | $32.86M | +13.2% |
| Q3 FY2025 | Sep 30, 2025 | $52.58M | -12.3% |
| Q2 FY2025 | Jun 30, 2025 | $35.59M | -48.5% |
| Q1 FY2025 | Mar 31, 2025 | $35.08M | -36.6% |
| Q4 FY2024 | Dec 31, 2024 | $29.02M | +21.6% |
| Q3 FY2024 | Sep 30, 2024 | $59.96M | -6.8% |
| Q2 FY2024 | Jun 30, 2024 | $69.11M | +25.8% |
| Q1 FY2024 | Mar 31, 2024 | $55.29M | +36.9% |
| Q4 FY2023 | Dec 31, 2023 | $23.86M | +56.7% |
| Q3 FY2023 | Sep 30, 2023 | $64.33M | +215.7% |
| Q2 FY2023 | Jun 30, 2023 | $54.92M | +1851.1% |
| Q1 FY2023 | Mar 31, 2023 | $40.38M | -20.5% |
| Q4 FY2022 | Dec 31, 2022 | $15.23M | -62.4% |
| Q3 FY2022 | Sep 30, 2022 | $20.38M | +693.1% |
| Q2 FY2022 | Jun 30, 2022 | $2.82M | -91.2% |
| Q1 FY2022 | Mar 31, 2022 | $50.77M | +122.4% |
| Q4 FY2021 | Dec 31, 2021 | $40.44M | +139.4% |
| Q3 FY2021 | Sep 30, 2021 | $2.57M | -70.8% |
| Q2 FY2021 | Jun 30, 2021 | $32.16M | +6.9% |
| Q1 FY2021 | Mar 31, 2021 | $22.83M | +1445.4% |
| Q4 FY2020 | Dec 31, 2020 | $16.89M | +198.9% |
| Q3 FY2020 | Sep 30, 2020 | $8.81M | – |
| Q2 FY2020 | Jun 30, 2020 | $30.09M | -41.8% |
| Q1 FY2020 | Mar 31, 2020 | $1.48M | – |
| Q4 FY2019 | Dec 31, 2019 | $5.65M | -40.6% |
| Q3 FY2019 | Sep 30, 2019 | -$12.00M | -176.1% |
| Q2 FY2019 | Jun 30, 2019 | $51.72M | +1041.0% |
| Q1 FY2019 | Mar 31, 2019 | -$3.61M | -143.2% |
| Q4 FY2018 | Dec 31, 2018 | $9.52M | -2.5% |
| Q3 FY2018 | Sep 30, 2018 | $15.78M | +538.4% |
| Q2 FY2018 | Jun 30, 2018 | $4.53M | -0.9% |
| Q1 FY2018 | Mar 31, 2018 | $8.36M | -62.7% |
| Q4 FY2017 | Dec 31, 2017 | $9.77M | -30.3% |
| Q3 FY2017 | Sep 30, 2017 | $2.47M | – |
| Q2 FY2017 | Jun 30, 2017 | $4.57M | – |
| Q1 FY2017 | Mar 31, 2017 | $22.40M | – |
| Q4 FY2016 | Dec 31, 2016 | $14.01M | – |
See a number that looks wrong?